Ai.Qimia Physica-based ai for Chemical Process Development

In drug discovery, the headlines go to finding molecules—but 90% of candidates fail during process chemistry: the hard, expensive work of scaling synthesis. Most drug IP today simply never reaches patients.

Ai.Qimia solves this. Our physics-informed AI will model real lab conditions—temperature, solvents, catalysts—and predict successful synthesis scale-up, learning even from negative experimental data (a major blind spot today).

We’re launching from a decade of proprietary software and rich experimental data. Our initial SaaS platform will serve biotechs, CROs, and chemistry teams—building revenue and critical data assets from Day 1.